Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats
Authors:
- 17 August 2005
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 383 (2) , 224-234
Abstract
Time courses of changes in manganese, iron, copper, and zinc concentrations were examined in regions of the brain of a 6-hydroxydopamine (6-OHDA)-induced rat model of Parkinson’s disease using inductively coupled plasma mass spectrometry (ICP-MS). The concentrations were simultaneously determined in brain section at the level of the substantia nigra 1, 3, 7, 10, 14, and 21 days after the 6-OHDA treatment and compared with those of control rats. The distributions of these elements were obtained for 18 regions of the sagittal section (1-mm thick). The ICP-MS results indicated that Mn, Fe, Cu, and Zn levels of the 6-OHDA-induced parkinsonian brain were observed to increase in all regions that lay along the dopaminergic pathway. In the substantia nigra, the increase in Mn level occurred rapidly from 3 to 7 days and preceded those in the other elements, reaching a plateau in the 6-OHDA brain. Iron and Zn levels increased gradually until 7 days and then increased rapidly from 7 to 10 days. The increase in the copper level was slightly delayed. In other regions, such as the globus pallidus, putamen, and amygdala, the levels of Mn, Fe, Cu, and Zn increased with time after 6-OHDA treatment, although the time courses of their changes were region-specific. These findings contribute to our understanding of the roles of Mn and Fe in the induction of neurological symptoms and progressive loss of dopaminergic neurons in the development of Parkinson’s disease. Manganese may hold the key to disturbing cellular Fe homeostasis and accelerating Fe levels, which play the most important role in the development of Parkinson’s disease.Keywords
This publication has 23 references indexed in Scilit:
- Regional distribution of manganese, iron, copper, and zinc in the rat brain during developmentAnalytical and Bioanalytical Chemistry, 2004
- Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigraBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2003
- Trace element speciation in largemouth bass (Micropterus salmoides) from a fly ash settling basin by liquid chromatography-ICP-MSAnalytical and Bioanalytical Chemistry, 2002
- Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Trace element analysis in CRM of plant origin by inductively coupled plasma mass spectrometryAnalytical and Bioanalytical Chemistry, 1998
- Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy studyBrain Research, 1996
- Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expressionExperimental Brain Research, 1996
- Oxidative stress and antioxidant therapy in Parkinson's diseaseProgress in Neurobiology, 1996
- ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIABrain, 1991
- Titanium nitride as a coating for surgical instruments used to collect human tissue for trace metal analysisThe Analyst, 1990